← Open Payments lookup

ANDREW KIRSCH: Open Payments

NPI 1992925101 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,032 in 16 payments from 6 companies in 2025. Trend: 2023 $361 · 2024 $598 · 2025 $3,032

Consulting: $1,840Food & beverage: $1,192
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.6$2,157
Alkermes, Inc.4$385
Otsuka America Pharmaceutical, Inc.3$346
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$105
Novo Nordisk Inc1$21
ABBVIE INC.1$18

Products named: COBENFY, LYBALVI, REXULTI, ARISTADA, ABILIFY MAINTENA, CAPLYTA, VRAYLAR.

Industry payments across NY — which companies pay providers there.